While, 151 UTX mutations in 139 cases (9 carry dual‐mutations, and 1 carry 4‐mutations) are identified in total 510 bladder cancer cases, indicating a 29.6% UTX mutation rate. This evidence concerns the gene KDM6A and urinary bladder cancer.